Literature DB >> 23695006

[S3 guidelines on bipolar disorders are contemporary and important instruments for clinical practice. For].

A Pfennig1, M Bauer.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 23695006     DOI： 10.1007/s00115-013-3796-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  4 in total

1.  [Phytochemicals as means to induce sleep].

Authors:  H P Volz
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2001-01

2.  [The concept of the development of S3 guidelines: additional benefit compared to traditional standards, problems and solutions].

Authors:  A Pfennig; I Kopp; D Strech; M Bauer
Journal:  Nervenarzt       Date:  2010-09       Impact factor: 1.214

Review 3.  Quality of reporting of randomized controlled trials of pharmacologic treatment of bipolar disorders: a systematic review.

Authors:  Daniel Strech; Bettina Soltmann; Beate Weikert; Michael Bauer; Andrea Pfennig
Journal:  J Clin Psychiatry       Date:  2011-01-25       Impact factor: 4.384

4.  [S3 guidelines on diagnostics and therapy of bipolar disorders: development process and essential recommendations].

Authors:  A Pfennig; T Bschor; T Baghai; P Bräunig; P Brieger; P Falkai; D Geissler; R Gielen; H Giesler; O Gruber; I Kopp; T D Meyer; K H Möhrmann; C Muche-Borowski; F Padberg; H Scherk; D Strech; M Bauer
Journal:  Nervenarzt       Date:  2012-05       Impact factor: 1.214
  4 in total
  3 in total

Review 1.  [Psychopharmaceuticals for treatment of suicidal patients and for suicide prevention].

Authors:  R Haußmann; M Bauer; U Lewitzka; B Müller-Oerlinghausen
Journal:  Nervenarzt       Date:  2016-05       Impact factor: 1.214

2.  The suicide prevention effect of lithium: more than 20 years of evidence-a narrative review.

Authors:  U Lewitzka; E Severus; R Bauer; P Ritter; B Müller-Oerlinghausen; M Bauer
Journal:  Int J Bipolar Disord       Date:  2015-07-18

3.  Does lithium reduce acute suicidal ideation and behavior? A protocol for a randomized, placebo-controlled multicenter trial of lithium plus Treatment As Usual (TAU) in patients with suicidal major depressive episode.

Authors:  U Lewitzka; B Jabs; M Fülle; V Holthoff; G Juckel; I Uhl; S Kittel-Schneider; A Reif; C Reif-Leonhard; O Gruber; B Djawid; S Goodday; R Haussmann; A Pfennig; P Ritter; J Conell; E Severus; M Bauer
Journal:  BMC Psychiatry       Date:  2015-05-19       Impact factor: 3.630
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.